Synthesis and antibacterial potential of novel thymol derivatives against methicillin-resistant Staphylococcus aureus and P. aeruginosa pathogenic bacteria.

IF 3.8 3区 化学 Q2 CHEMISTRY, MULTIDISCIPLINARY Frontiers in Chemistry Pub Date : 2024-10-16 eCollection Date: 2024-01-01 DOI:10.3389/fchem.2024.1482852
Ashutosh Shahi, Rakshit Manhas, Srija Bhattacharya, Arti Rathore, Puneet Kumar, Jayanta Samanta, Manish Kumar Sharma, Avisek Mahapa, Prasoon Gupta, Jasha Momo H Anal
{"title":"Synthesis and antibacterial potential of novel thymol derivatives against methicillin-resistant <i>Staphylococcus aureus</i> and <i>P. aeruginosa</i> pathogenic bacteria.","authors":"Ashutosh Shahi, Rakshit Manhas, Srija Bhattacharya, Arti Rathore, Puneet Kumar, Jayanta Samanta, Manish Kumar Sharma, Avisek Mahapa, Prasoon Gupta, Jasha Momo H Anal","doi":"10.3389/fchem.2024.1482852","DOIUrl":null,"url":null,"abstract":"<p><p>The increasing threat of antibiotic resistance has created an urgent need for new antibacterial agents, particularly plant-based natural compounds and their derivatives. Thymol, a natural monoterpenoid phenolic compound derived from <i>Monarda citriodora</i>, is known for its aromatic and therapeutic properties, including antibacterial activity. This study focuses on synthesizing dihydropyrimidinone and dihydropyridine derivatives of thymol and exploring their antibacterial properties. The synthesized compounds were tested for their <i>in vitro</i> antibacterial potential against pathogenic microorganisms, specifically <i>Pseudomonas aeruginosa</i> (Gram-negative) and methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) (Gram-positive). Among the synthesized derivatives, compound 3i (ethyl 4-(4-hydroxy-5-isopropyl-2-methylphenyl)-2-imino-6-methyl-1,2,3,4-tetrahydropyrimidine-5-carboxylate) exhibited the most promising antibacterial activity, with minimum inhibitory concentration (MIC) values of 12.5 µM against <i>P. aeruginosa</i> and 50.0 µM against MRSA. Additionally, compound 3i demonstrated a synergistic effect when combined with vancomycin, enhancing its antibacterial efficacy. The optimum fractional inhibitory concentration index (FICI) observed was 0.10 and 0.5 for MRSA and <i>P. aeruginosa</i>, respectively, in combination with vancomycin. <i>In silico</i> analysis of the physiochemical properties of 3i indicated compliance with all drug-likeness rules. Furthermore, molecular docking studies revealed that compound 3i has a stronger binding affinity to the target protein than thymol, providing valuable insights into its potential mechanism of action.</p>","PeriodicalId":12421,"journal":{"name":"Frontiers in Chemistry","volume":"12 ","pages":"1482852"},"PeriodicalIF":3.8000,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11523063/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Chemistry","FirstCategoryId":"92","ListUrlMain":"https://doi.org/10.3389/fchem.2024.1482852","RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0

Abstract

The increasing threat of antibiotic resistance has created an urgent need for new antibacterial agents, particularly plant-based natural compounds and their derivatives. Thymol, a natural monoterpenoid phenolic compound derived from Monarda citriodora, is known for its aromatic and therapeutic properties, including antibacterial activity. This study focuses on synthesizing dihydropyrimidinone and dihydropyridine derivatives of thymol and exploring their antibacterial properties. The synthesized compounds were tested for their in vitro antibacterial potential against pathogenic microorganisms, specifically Pseudomonas aeruginosa (Gram-negative) and methicillin-resistant Staphylococcus aureus (MRSA) (Gram-positive). Among the synthesized derivatives, compound 3i (ethyl 4-(4-hydroxy-5-isopropyl-2-methylphenyl)-2-imino-6-methyl-1,2,3,4-tetrahydropyrimidine-5-carboxylate) exhibited the most promising antibacterial activity, with minimum inhibitory concentration (MIC) values of 12.5 µM against P. aeruginosa and 50.0 µM against MRSA. Additionally, compound 3i demonstrated a synergistic effect when combined with vancomycin, enhancing its antibacterial efficacy. The optimum fractional inhibitory concentration index (FICI) observed was 0.10 and 0.5 for MRSA and P. aeruginosa, respectively, in combination with vancomycin. In silico analysis of the physiochemical properties of 3i indicated compliance with all drug-likeness rules. Furthermore, molecular docking studies revealed that compound 3i has a stronger binding affinity to the target protein than thymol, providing valuable insights into its potential mechanism of action.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
新型百里酚衍生物的合成及其对耐甲氧西林金黄色葡萄球菌和绿脓杆菌的抗菌潜力。
抗生素耐药性的威胁日益严重,因此迫切需要新的抗菌剂,特别是植物性天然化合物及其衍生物。百里酚(Thymol)是一种天然单萜酚类化合物,提取自 Monarda citriodora,因其芳香和治疗特性(包括抗菌活性)而闻名。本研究的重点是合成百里酚的二氢嘧啶酮和二氢吡啶衍生物,并探索它们的抗菌特性。研究人员对合成的化合物进行了体外抗菌潜力测试,测试对象为病原微生物,特别是铜绿假单胞菌(革兰氏阴性)和耐甲氧西林金黄色葡萄球菌(MRSA)(革兰氏阳性)。在合成的衍生物中,化合物 3i(4-(4-羟基-5-异丙基-2-甲基苯基)-2-亚氨基-6-甲基-1,2,3,4-四氢嘧啶-5-羧酸乙酯)表现出最有希望的抗菌活性,对绿脓杆菌的最小抑菌浓度 (MIC) 值为 12.5 µM,对 MRSA 的最小抑菌浓度 (MIC) 值为 50.0 µM。此外,化合物 3i 与万古霉素联用时显示出协同效应,增强了其抗菌功效。在与万古霉素联用时,对 MRSA 和铜绿假单胞菌的最佳分数抑制浓度指数(FICI)分别为 0.10 和 0.5。对 3i 生理化学性质的硅学分析表明,它符合所有药物相似性规则。此外,分子对接研究表明,化合物 3i 与靶蛋白的结合亲和力强于百里酚,为了解其潜在的作用机制提供了宝贵的信息。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Frontiers in Chemistry
Frontiers in Chemistry Chemistry-General Chemistry
CiteScore
8.50
自引率
3.60%
发文量
1540
审稿时长
12 weeks
期刊介绍: Frontiers in Chemistry is a high visiblity and quality journal, publishing rigorously peer-reviewed research across the chemical sciences. Field Chief Editor Steve Suib at the University of Connecticut is supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to academics, industry leaders and the public worldwide. Chemistry is a branch of science that is linked to all other main fields of research. The omnipresence of Chemistry is apparent in our everyday lives from the electronic devices that we all use to communicate, to foods we eat, to our health and well-being, to the different forms of energy that we use. While there are many subtopics and specialties of Chemistry, the fundamental link in all these areas is how atoms, ions, and molecules come together and come apart in what some have come to call the “dance of life”. All specialty sections of Frontiers in Chemistry are open-access with the goal of publishing outstanding research publications, review articles, commentaries, and ideas about various aspects of Chemistry. The past forms of publication often have specific subdisciplines, most commonly of analytical, inorganic, organic and physical chemistries, but these days those lines and boxes are quite blurry and the silos of those disciplines appear to be eroding. Chemistry is important to both fundamental and applied areas of research and manufacturing, and indeed the outlines of academic versus industrial research are also often artificial. Collaborative research across all specialty areas of Chemistry is highly encouraged and supported as we move forward. These are exciting times and the field of Chemistry is an important and significant contributor to our collective knowledge.
期刊最新文献
Emerging NO2 gas sensing on substitutionally doped Fe on NiWO4 SCES insulators. Supramolecular systems and their connection with metal-organic structures. Carborane-based BODIPY dyes: synthesis, structural analysis, photophysics and applications. Flame retardants of the future: biobased, organophosphorus, reactive or oligomeric. Laser-induced graphene gas sensors for environmental monitoring.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1